18.11.2024 • News

CEFIC Re-elects Ilham Kadri as President

Ilham Kadri, CEO of Syensqo, has been re-elected as president of CEFIC, the European Chemical Industry Council, for a two-year term, effective immediately.

“It is an honor to serve this extraordinary industry at such a critical time. Together, we are proving the power of partnership, driving innovation, and tackling Europe’s greatest challenges – from climate change to industrial resilience. The world is watching Europe, and the chemical industry – ‘the mother of all industries’ – is the foundation of a sustainable and competitive future. My commitment remains firm: to support our sector’s transition while ensuring Europe remains a competitive hub for innovation, investment, and opportunity,” Kadri said.

According to CEFIC, Kadri will also take on the role of president of the International Council of Chemical Associations (ICCA) on Jan. 1, 2025, during CEFIC’s two-year mandate.

Marco Mensink, CEFIC director general, commented: “Ilham’s passion and commitment to our sector are unmatched. She has inspired a united vision within CEFIC and strengthened our relationships with Europe’s key decision-makers. Her leadership gives our sector a strong voice as we advocate for practical solutions that keep Europe competitive and sustainable.”

Ilham Kadri, CEO of Syensqo, has been re-elected as president of the European...
Ilham Kadri, CEO of Syensqo, has been re-elected as president of the European Chemical Industry Council, CEFIC | © Syensqo/CEFIC

Company

Logo:

European Chemical Industry Council - Cefic aisbl

Avenue Van Nieuwenhuyse 4
1160 Brüssel
Belgium

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.